• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子结构和 PCA 分析共价和非共价乙酰胆碱酯酶抑制剂。

Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors.

机构信息

Laboratório de Química Computacional, LQC, Universidade de Brasília, Instituto de Química, Brasília, DF, Brazil.

出版信息

J Mol Model. 2011 Jun;17(6):1371-9. doi: 10.1007/s00894-010-0838-x. Epub 2010 Sep 14.

DOI:10.1007/s00894-010-0838-x
PMID:20839017
Abstract

Hartree-Fock and density functional methods were used to analyze electronic and structural properties of known drugs to evaluate the influence of these data on acetylcholinesterase inhibition. The energies of the frontier orbitals and the distances between the more acidic hydrogen species were investigated to determine their contributions to the activity of a group of acetylcholinesterase inhibitors. Electrostatic potential maps indicated suitable sites for drugs-enzyme interactions. In this study, the structural, electronic and spatial properties of nine drugs with known inhibitory effects on acetylcholinesterase were examined. The data were obtained based on calculations at the B3LYP/6-31 + G(d,p) level. Multivariate principal components analysis was applied to 18 parameters to determine the pharmacophoric profile of acetylcholinesterase inhibitors. Desirable features for acetylcholinesterase inhibitor molecules include aromatic systems or groups that simulate the surface electrostatic potential of aromatic systems and the presence of a sufficient number of hydrogen acceptors and few hydrogen donors. PCA showed that electronic properties, including the HOMO-1 orbital energy, logP and aromatic system quantity, as well as structural data, such as volume, size and H-H distance, are the most significant properties.

摘要

采用 Hartree-Fock 和密度泛函方法分析了已知药物的电子和结构性质,以评估这些数据对乙酰胆碱酯酶抑制的影响。研究了前线轨道的能量和更酸性氢物种之间的距离,以确定它们对一组乙酰胆碱酯酶抑制剂活性的贡献。静电势图表明了适合药物-酶相互作用的部位。在这项研究中,检查了九种具有已知乙酰胆碱酯酶抑制作用的药物的结构、电子和空间性质。这些数据是基于 B3LYP/6-31 + G(d,p) 水平的计算获得的。应用多元主成分分析对 18 个参数进行了分析,以确定乙酰胆碱酯酶抑制剂的药效团特征。乙酰胆碱酯酶抑制剂分子的理想特征包括模拟芳香系统表面静电势的芳香系统或基团,以及存在足够数量的氢键受体和较少的氢键供体。PCA 表明,电子性质,包括 HOMO-1 轨道能量、logP 和芳香系统数量,以及结构数据,如体积、大小和 H-H 距离,是最重要的性质。

相似文献

1
Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors.电子结构和 PCA 分析共价和非共价乙酰胆碱酯酶抑制剂。
J Mol Model. 2011 Jun;17(6):1371-9. doi: 10.1007/s00894-010-0838-x. Epub 2010 Sep 14.
2
Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.鉴定用于设计新型异咯嗪衍生物的分子描述符,这些衍生物作为潜在的抗阿尔茨海默病乙酰胆碱酯酶抑制剂。
J Biomol Struct Dyn. 2017 Jun;35(8):1729-1742. doi: 10.1080/07391102.2016.1192485. Epub 2016 Jul 28.
3
New potential AChE inhibitor candidates.新型潜在乙酰胆碱酯酶抑制剂候选物。
Eur J Med Chem. 2009 Sep;44(9):3754-9. doi: 10.1016/j.ejmech.2009.03.045. Epub 2009 Apr 16.
4
Electronic structure and conformational properties of 1H-indole-3-acetic acid.1H-吲哚-3-乙酸的电子结构和构象性质。
J Mol Model. 2011 Jun;17(6):1227-39. doi: 10.1007/s00894-010-0804-7. Epub 2010 Aug 13.
5
Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.协同氢键和非芳香环的流动性作为人类乙酰胆碱酯酶对类似抗阿尔茨海默病加兰他敏类化合物的选择性决定因素:一项计算研究。
J Biomol Struct Dyn. 2019 Apr;37(7):1843-1856. doi: 10.1080/07391102.2018.1470036. Epub 2018 May 17.
6
Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies.通过对接研究预测石杉碱甲在乙酰胆碱酯酶中的结合位点
J Comput Aided Mol Des. 1994 Dec;8(6):669-81. doi: 10.1007/BF00124014.
7
Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods.使用三维定量构效关系(3D-QSAR)方法预测有机磷对乙酰胆碱酯酶的抑制作用。
Toxicol Sci. 2001 Oct;63(2):223-32. doi: 10.1093/toxsci/63.2.223.
8
Experimental and computational studies on the inhibition of acetylcholinesterase by curcumin and some of its derivatives.姜黄素及其某些衍生物对乙酰胆碱酯酶抑制作用的实验与计算研究
Curr Comput Aided Drug Des. 2013 Jun;9(2):289-98. doi: 10.2174/15734099113099990007.
9
A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.组合特征选择方法描述乙酰胆碱酯酶双重位点抑制剂的定量构效关系。
Comput Biol Med. 2009 Dec;39(12):1089-95. doi: 10.1016/j.compbiomed.2009.09.003. Epub 2009 Oct 24.
10
Towards improved acetylcholinesterase inhibitors: a structural and computational approach.迈向更优的乙酰胆碱酯酶抑制剂:一种结构与计算方法。
Mini Rev Med Chem. 2001 Sep;1(3):255-66. doi: 10.2174/1389557013406828.

引用本文的文献

1
Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies.吡唑啉作为潜在的抗阿尔茨海默病药物:密度泛函理论、分子对接、酶抑制及药代动力学研究
RSC Med Chem. 2022 Oct 18;13(12):1644-1656. doi: 10.1039/d2md00262k. eCollection 2022 Dec 14.
2
In silico study of tacrine and acetylcholine binding profile with human acetylcholinesterase: docking and electronic structure.他克林与人乙酰胆碱酯酶结合特性的计算研究:对接和电子结构。
J Mol Model. 2022 Aug 10;28(9):252. doi: 10.1007/s00894-022-05252-2.
3
Structure-activity relationship of tacrine and its analogues in relation to inhibitory activity against Alzheimer's disease.

本文引用的文献

1
New potential AChE inhibitor candidates.新型潜在乙酰胆碱酯酶抑制剂候选物。
Eur J Med Chem. 2009 Sep;44(9):3754-9. doi: 10.1016/j.ejmech.2009.03.045. Epub 2009 Apr 16.
2
Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors.来自石杉碱甲的双价配体作为乙酰胆碱酯酶抑制剂。
Curr Top Med Chem. 2007;7(4):375-87. doi: 10.2174/156802607779941215.
3
In-situ synthesis of a tacrine-triazole-based inhibitor of acetylcholinesterase: configurational selection imposed by steric interactions.基于他克林-三唑的乙酰胆碱酯酶抑制剂的原位合成:空间相互作用导致的构型选择
他克林及其类似物与抑制阿尔茨海默病活性的构效关系。
J Mol Model. 2019 Apr 11;25(5):116. doi: 10.1007/s00894-019-3993-8.
4
Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds.结合对接和分子动力学的相似性搜索用于新型人乙酰胆碱酯酶抑制剂支架
J Mol Model. 2018 Jan 13;24(1):41. doi: 10.1007/s00894-017-3548-9.
5
Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.潜在的乙酰胆碱酯酶抑制剂:分子对接、分子动力学及计算机模拟预测
J Mol Model. 2017 Feb;23(2):67. doi: 10.1007/s00894-017-3228-9. Epub 2017 Feb 9.
6
Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.新型植物化学-抗生素缀合物作为铜绿假单胞菌GyrB/ParE和二氢叶酸还原酶的多靶点抑制剂
Drug Des Devel Ther. 2013 Jun 17;7:449-75. doi: 10.2147/DDDT.S43964. Print 2013.
7
Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.金雀花碱相互作用位点的映射:通过成对势能和量子化学进行定量分析。
J Comput Aided Mol Des. 2012 Oct;26(10):1111-26. doi: 10.1007/s10822-012-9602-x. Epub 2012 Sep 13.
J Med Chem. 2006 Oct 19;49(21):6222-30. doi: 10.1021/jm051132b.
4
Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.亚烷基连接的他克林二聚体与加州电鳐乙酰胆碱酯酶的复合物:双5-他克林的结合导致活性位点峡谷发生显著重排。
J Med Chem. 2006 Sep 7;49(18):5491-500. doi: 10.1021/jm060164b.
5
Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.乙酰胆碱酯酶共价和非共价抑制剂功能分析为阿尔茨海默病治疗药物设计提供的经验教训。
Chem Biol Interact. 2005 Dec 15;157-158:219-26. doi: 10.1016/j.cbi.2005.10.030. Epub 2005 Nov 11.
6
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.构象受限的卡巴拉汀类似物的设计、合成及生物学评价
J Med Chem. 2004 Nov 18;47(24):5945-52. doi: 10.1021/jm049782n.
7
Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.基于柔性对接的高通量虚拟筛选高效方法:新型乙酰胆碱酯酶抑制剂的发现
J Med Chem. 2004 Sep 23;47(20):4818-28. doi: 10.1021/jm030605g.
8
Acetylcholinesterase inhibitors: novel activities of old molecules.乙酰胆碱酯酶抑制剂:旧分子的新活性。
Pharmacol Res. 2004 Oct;50(4):441-51. doi: 10.1016/j.phrs.2003.12.027.
9
Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.开环D环加兰他敏类似物的合成及其构效关系
Bioorg Med Chem Lett. 2003 Jul 21;13(14):2389-91. doi: 10.1016/s0960-894x(03)00397-4.
10
Towards improved acetylcholinesterase inhibitors: a structural and computational approach.迈向更优的乙酰胆碱酯酶抑制剂:一种结构与计算方法。
Mini Rev Med Chem. 2001 Sep;1(3):255-66. doi: 10.2174/1389557013406828.